Anxiety Management for Anxiety Disorders
(PACER Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine which of three treatments best manages anxiety in individuals who recently visited an emergency department with chest pain but were not diagnosed with a heart problem. The treatments compared include an online self-administered anxiety management program with peer support, therapist-led cognitive behavioral therapy (CBT) through telehealth, and enhanced primary care follow-up. Individuals who have experienced chest pain, have moderate to severe anxiety, and are expected to be released from the emergency department within 24 hours might be suitable candidates. As an unphased trial, this study provides a unique opportunity to explore innovative anxiety treatments and contribute to valuable research.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that the Online Self-Administered Anxiety Management Program, combined with peer support, is generally easy to use. Studies have found that digital programs like this are usually safe, with few reports of negative effects. Many participants find these programs helpful for managing anxiety.
Therapist-Administered Cognitive Behavioral Therapy (CBT) is also recognized as a safe and effective treatment for anxiety. Most people do not experience major side effects. However, some studies have noted that a few patients might feel more anxious temporarily, and a small number might discontinue therapy. Overall, CBT is considered a top treatment with a strong record of safety and effectiveness.12345Why are researchers excited about this trial's treatments?
Researchers are excited about these treatments for anxiety disorders because they offer new ways to tackle the condition. The Online Self-Administered Anxiety Management Program, combined with Peer Support Guidance, allows people to manage their anxiety from the comfort of their home, making it more accessible and flexible than traditional face-to-face therapy. This program also includes peer support, which can provide additional encouragement and accountability. Meanwhile, the Therapist-Administered Cognitive Behavioral Therapy is delivered via telehealth, offering the convenience of virtual sessions while still providing personalized, professional guidance. Both methods expand access to effective anxiety treatment, catering to individuals who may not have the means or time to attend in-person therapy sessions.
What evidence suggests that this trial's treatments could be effective for anxiety disorders?
Research has shown that online cognitive behavioral therapy (CBT) programs, especially when combined with peer support, can greatly reduce anxiety symptoms. These programs are user-friendly and help individuals manage anxiety through structured, self-guided sessions. Studies highlight that peer support enhances these programs by providing encouragement and shared experiences. Participants in this trial may receive the Online Self-Administered Anxiety Management Program plus Peer Support Guidance.
Therapist-led cognitive behavioral therapy (CBT) is another treatment option in this trial and is also highly effective for treating anxiety. Research indicates that up to 57% of people with generalized anxiety disorder recover within 12 months of starting therapy, demonstrating its long-term effectiveness. Therapist-led sessions offer personalized guidance and have proven more effective than usual treatment methods. Both treatment options in this trial can reduce anxiety, but they offer different levels of interaction and support.23456Who Is on the Research Team?
Paul Musey, MD
Principal Investigator
Indiana University
Are You a Good Fit for This Trial?
This trial is for adults who visited the ER with low-risk chest pain and have moderate to severe anxiety. They must have a certain score on heart risk and anxiety assessments, be expected to leave the ER within 24 hours, and speak English. People admitted as inpatients or with active psychosis, traumatic chest pain, unstable vital signs, homelessness, or inability to follow up are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomly assigned to one of three anxiety treatment arms: enhanced primary care coordination, online CBT with peer support, or therapist-led CBT via tele-health
Follow-up
Participants are monitored for anxiety symptoms, ED utilization, and other health outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Online Self-Administered Anxiety Management Program plus Peer Support Guidance
- Primary care follow-up
- Therapist-Administered Cognitive Behavioral Therapy
Find a Clinic Near You
Who Is Running the Clinical Trial?
Indiana University
Lead Sponsor
Patient-Centered Outcomes Research Institute
Collaborator